Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

 

Search in our Online Store

Cardiovascular, Blood & Acute Care
Filter     Order     Display # 
Date Item Title Hits
16 Mar 2010 Lantheus Medical Imaging, Inc. Presents Preliminary Phase 2 Data With Flurpiridaz F 18 (BMS747158), a Novel PET Cardiac Imaging Agent, at the American College Of Cardiology 59th Annual Scientific Session -
15 Mar 2010 Portola Pharmaceuticals and Merck Announce that Phase 2 Study Showed Investigational Factor Xa Inhibitor, Betrixaban, Reduced Incidence of Bleeding Compared to Warfarin in Patients with Atrial Fibrillation 6
15 Mar 2010 Dabigatran etexilate shows greater reductions than warfarin in stroke in patients with atrial fibrillation across all stroke risk groups 5
15 Mar 2010 Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010 1
14 Mar 2010 XOMA 052 Prevents Adverse Cardiac Remodeling in Animal Model of Heart Attack 3
12 Mar 2010 Sanofi-aventis and Bristol-Myers Squibb Announce Important Updates to PLAVIX U.S. Prescribing Information 7
12 Mar 2010 GlaxoSmithKline receives marketing authorisation in the EU for Revolade (eltrombopag) 8
11 Mar 2010 ProFibrix Reports Phase II Results of Hemostasis Product Fibrocaps(TM) and Appoints New Chief Medical Officer 4
10 Mar 2010 Start of Phase I/II Gene Therapy Clinical Trial for Hemophilia B 8
09 Mar 2010 Aastrom Announces Treatment of Final Patient in IMPACT-DCM Surgical Clinical Trial 6
09 Mar 2010 Bristol-Myers Squibb and AstraZeneca Announce the Commencement of the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus Trial (SAVOR-TIMI 53) 5
09 Mar 2010 Ischemix Initiates Phase 2a Trial of CMX-2043 for the Prevention of Ischemia-Reperfusion Injury 5
05 Mar 2010 ADVANCE-2 Study Results Demonstrate Investigational Anticoagulant Apixaban Was Statistically Superior to Enoxaparin in the Prevention of Venous Thromboembolism Following Knee Replacement Surgery 10
02 Mar 2010 Pluristem Therapeutics Receives DSMB Approval to Advance to Final Dose Level With PLX-PAD 26
26 Feb 2010 Agennix AG Announces Longer-Term Mortality Results From Talactoferrin Phase 2 Trial in Severe Sepsis 50
25 Feb 2010 AFFiRiS AG: vaccination against hypertension is development project no. 4 and has already been awarded an FFG grant of up to 1.2 million. 13
24 Feb 2010 Aastrom Reports Interim Results From Critical Limb Ischemia Trial 8
23 Feb 2010 Forest Laboratories Receives Decision from FDA for Supplemental New Drug Application for Bystolic(R) 24
19 Feb 2010 United Therapeutics Corporation Withdraws European Marketing Authorization Application for Tyvaso for the Treatment of Pulmonary Arterial Hypertension 45
18 Feb 2010 Biogen Idec and Swedish Orphan Biovitrum Update Hemophilia Partnership Agreement 12
16 Feb 2010 Athersys Announces Completion of Patient Enrollment in Phase I Study of Multistem(R) in Acute Myocardial Infarction 15
11 Feb 2010 FDA Approves Benicar(R) for the Treatment of High Blood Pressure in Children and Adolescents aged 6-16 81
08 Feb 2010 US FDA Approves New Indication for CRESTOR(R) (rosuvastatin calcium) 39
04 Feb 2010 Bioheart Launches First US FDA Approved Clinical Trial that Tests Gene-Modified Stem Cell Therapy in Patients with Congestive Heart Failure 78
03 Feb 2010 APEIRON AND GSK SIGN AN EXCLUSIVE LICENSE AGREEMENT FOR APEIRON'S THERAPEUTIC ENZYME PROJECT APN01 23
03 Feb 2010 Daiichi Sankyo Initiates Largest Single, Double-Blind, Randomized, Phase III Trial for Treatment and Prevention of Recurrent Venous Thromboembolism 26
01 Feb 2010 Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel(R) 37
28 Jan 2010 GTC Provides Recombinant FVIIa Regulatory Update 33
28 Jan 2010 First Refractory Angina Patient treated with VEGF-D shortform (EG011) in Phase I/IIa trial 58
26 Jan 2010 Cardium Provides Update on Commercial Development Plans for Generx Angiogenic Therapy for Heart Disease at 2010 Cell & Gene Therapy Forum 25
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 1 - 30 of 1335

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Biologic and Immune Therapy of S. aureus Infections

Order Now

Recommended Report

Oncology Market Leaders
Order Now

Subscribe La Merie Biologics